IMA

IMA
Immune cell ‘bloodhounds’ track cancer cells’ unique metabolic signatures, eliminate tumors in mice
Institute Scholars
IMA
Lighting up the gut to detect celiac disease
Employee spotlights
IMA
Get to know Jason Pellman–Scientific Program Manager
IMA
The Stanford IMA unveils new Cell and Gene Therapies Lab
IMA
Institute Scholars
People of Stanford Research Park: Chaitan Khosla
Institute Scholars
IMA
Outrunning the next pandemic
Institute Scholars
IMA
The future of antibiotic synthesis
IMA
Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories form a collaboration to fight cancerous neuroendocrine tumors
Institute Scholars
IMA
Durable, low-cost COVID-19 vaccine could help fill in gaps around the world
IMA
Stanford IMA and The Invus Group collaborate to develop glioblastoma drugs
IMA
Biotechnology incubator in Stanford Research Park anchors growing life sciences district
IMA
Deerfield and Stanford University Create the Porter Alliance for Innovative Medicines
ChEM-H-funded projects
IMA
Stanford researchers develop standardized method for extracting SARS-CoV-2 RNA from stool
IMA
A look inside Stanford’s expanded Biosafety Level 3 (BSL3) lab
IMA
Stanford pivots its Long-Range Vision to contribute to global recovery